Atea Pharmaceuticals Insider Trades
NASDAQ: AVIRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $25.45K
- Sales
- 6 · $319.80K
- Shares bought / sold
- 6.10K / 79.34K
- Net activity
- Net selling $294,358
Atea Pharmaceuticals insider activity
Over the last 12 months, Atea Pharmaceuticals insiders reported 32 transactions on SEC Form 4: 1 open-market purchase and 6 sales. Insiders bought $25,446 and sold $319,804 worth of stock, for net insider selling of $294,358. The largest seller was Polsky Bruce, with $203,393 in reported sales.
The most recent filing shows Polsky Bruce (Director) selling 8,750 shares at $4.03 on Nov 19, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AVIR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AVIR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 19, 2026 | Lucidi BrunoDirector | Sale | 22,619 | $89.22K | Form 4 |
| Nov 19, 2026 | Lucidi BrunoDirector | Option exercise | 53,372 | $66.18K | Form 4 |
| Nov 19, 2026 | Polsky BruceDirector | Sale | 8,750 | $35.30K | Form 4 |
| Nov 18, 2026 | Polsky BruceDirector | Sale | 18,252 | $72.10K | Form 4 |
| Nov 18, 2026 | Polsky BruceDirector | Option exercise | 18,252 | $22.63K | Form 4 |
| Nov 17, 2026 | Polsky BruceDirector | Sale | 8,720 | $35.16K | Form 4 |
| Nov 17, 2026 | Polsky BruceDirector | Option exercise | 8,720 | $10.81K | Form 4 |
| Nov 17, 2026 | Lucidi BrunoDirector | Sale | 6,741 | $27.19K | Form 4 |
| Nov 17, 2026 | Lucidi BrunoDirector | Option exercise | 21,628 | $26.82K | Form 4 |
| Nov 16, 2026 | Polsky BruceDirector | Sale | 14,254 | $60.84K | Form 4 |
| Nov 16, 2026 | Polsky BruceDirector | Option exercise | 48,028 | $59.55K | Form 4 |
| Jun 18, 2026 | Adams Jerome M.Director | Option exercise | 29,600 | — | Form 4 |
| Jun 18, 2026 | Polsky BruceDirector | Option exercise | 29,600 | — | Form 4 |
| Jun 18, 2026 | BERGER FRANKLIN MDirector | Option exercise | 29,600 | — | Form 4 |
| Jun 18, 2026 | Lucidi BrunoDirector | Option exercise | 29,600 | — | Form 4 |
| Jun 18, 2026 | Murphy Polly A.Director | Option exercise | 29,600 | — | Form 4 |
| Jun 18, 2026 | DUNCAN BARBARA GAYLEDirector | Option exercise | 29,600 | — | Form 4 |
| May 18, 2026 | Murphy Polly A.Director | Buy | 6,100 | $25.45K | Form 4 |
| Mar 11, 2026 | Corcoran AndreaSee Remarks | Option exercise | 60,000 | $74.40K | Form 4 |
| Feb 3, 2026 | Sommadossi Jean-PierrePresident, CEO, and Chairman | Option exercise | 300,000 | $372.00K | Form 4 |
| Jan 31, 2026 | Foster WayneEVP, Chief Accounting Officer | Tax withholding | 12,132 | $51.44K | Form 4 |
| Jan 31, 2026 | Foster WayneEVP, Chief Accounting Officer | Option exercise | 41,333 | — | Form 4 |
| Jan 31, 2026 | Sommadossi Jean-PierrePresident, CEO, and Chairman | Tax withholding | 106,093 | $449.83K | Form 4 |
| Jan 31, 2026 | Sommadossi Jean-PierrePresident, CEO, and Chairman | Option exercise | 272,983 | — | Form 4 |
| Jan 31, 2026 | Corcoran AndreaSee Remarks | Tax withholding | 16,104 | $68.28K | Form 4 |
| Jan 31, 2026 | Corcoran AndreaSee Remarks | Option exercise | 54,866 | — | Form 4 |
| Jan 31, 2026 | Hammond Janet MJChief Development Officer | Tax withholding | 14,136 | $59.94K | Form 4 |
| Jan 31, 2026 | Hammond Janet MJChief Development Officer | Option exercise | 58,050 | — | Form 4 |
| Jan 31, 2026 | Vavricka JohnChief Commercial Officer | Tax withholding | 11,570 | $49.06K | Form 4 |
| Jan 31, 2026 | Vavricka JohnChief Commercial Officer | Option exercise | 42,083 | — | Form 4 |
| Jan 31, 2026 | Horga Maria ArantxaChief Medical Officer | Tax withholding | 16,073 | $68.15K | Form 4 |
| Jan 31, 2026 | Horga Maria ArantxaChief Medical Officer | Option exercise | 51,283 | — | Form 4 |
| Jun 20, 2025 | Adams Jerome M.Director | Option exercise | 29,600 | — | Form 4 |
| Jun 20, 2025 | Polsky BruceDirector | Option exercise | 29,600 | — | Form 4 |
| Jun 20, 2025 | BERGER FRANKLIN MDirector | Option exercise | 29,600 | — | Form 4 |
| Jun 20, 2025 | Lucidi BrunoDirector | Option exercise | 29,600 | — | Form 4 |
| Jun 20, 2025 | Duncan Barbara GayleDirector | Option exercise | 29,600 | — | Form 4 |
| Jun 20, 2025 | Murphy Polly A.Director | Option exercise | 29,600 | — | Form 4 |
| May 18, 2025 | Murphy Polly A.Director | Buy | 6,100 | $25.45K | Form 4 |
| Jan 31, 2025 | Foster WayneEVP, Chief Accounting Officer | Tax withholding | 12,062 | $36.91K | Form 4 |
| Jan 31, 2025 | Foster WayneEVP, Chief Accounting Officer | Award | 8,000 | — | Form 4 |
| Jan 31, 2025 | Foster WayneEVP, Chief Accounting Officer | Option exercise | 33,333 | — | Form 4 |
| Jan 31, 2025 | Vavricka JohnChief Commercial Officer | Tax withholding | 11,517 | $35.24K | Form 4 |
| Jan 31, 2025 | Vavricka JohnChief Commercial Officer | Award | 8,750 | — | Form 4 |
| Jan 31, 2025 | Vavricka JohnChief Commercial Officer | Option exercise | 33,333 | — | Form 4 |
| Jan 31, 2025 | Sommadossi Jean-PierrePresident, CEO, and Chairman | Tax withholding | 88,601 | $271.12K | Form 4 |
| Jan 31, 2025 | Sommadossi Jean-PierrePresident, CEO, and Chairman | Award | 99,517 | — | Form 4 |
| Jan 31, 2025 | Sommadossi Jean-PierrePresident, CEO, and Chairman | Option exercise | 173,467 | — | Form 4 |
| Jan 31, 2025 | Corcoran AndreaSee Remarks | Tax withholding | 16,102 | $49.27K | Form 4 |
| Jan 31, 2025 | Corcoran AndreaSee Remarks | Award | 10,500 | — | Form 4 |
| Jan 31, 2025 | Corcoran AndreaSee Remarks | Option exercise | 44,367 | — | Form 4 |
| Jan 31, 2025 | Horga Maria ArantxaChief Medical Officer | Tax withholding | 16,071 | $49.18K | Form 4 |
| Jan 31, 2025 | Horga Maria ArantxaChief Medical Officer | Award | 9,750 | — | Form 4 |
| Jan 31, 2025 | Horga Maria ArantxaChief Medical Officer | Option exercise | 41,533 | — | Form 4 |
| Jan 31, 2025 | Hammond Janet MJChief Development Officer | Tax withholding | 14,134 | $43.25K | Form 4 |
| Jan 31, 2025 | Hammond Janet MJChief Development Officer | Award | 11,250 | — | Form 4 |
| Jan 31, 2025 | Hammond Janet MJChief Development Officer | Option exercise | 46,800 | — | Form 4 |
| Jan 16, 2025 | BERGER FRANKLIN MDirector | Buy | 10,000 | $33.61K | Form 4 |
| Jan 16, 2025 | BERGER FRANKLIN MDirector | Buy | 10,000 | $33.61K | Form 4 |
| Jan 15, 2025 | BERGER FRANKLIN MDirector | Buy | 15,000 | $47.88K | Form 4 |
| Jan 15, 2025 | BERGER FRANKLIN MDirector | Buy | 15,000 | $47.88K | Form 4 |
| Dec 10, 2024 | BERGER FRANKLIN MDirector | Sale | 359,606 | $1.02M | Form 4 |
| Sep 19, 2024 | Sommadossi Jean-PierrePresident, CEO, and Chairman | Sale | 1,841 | $7.37K | Form 4 |
| Sep 18, 2024 | Sommadossi Jean-PierrePresident, CEO, and Chairman | Sale | 22,187 | $89.47K | Form 4 |
| Sep 17, 2024 | Sommadossi Jean-PierrePresident, CEO, and Chairman | Sale | 33,941 | $137.32K | Form 4 |
| Jun 20, 2024 | Polsky BruceDirector | Sale | 17,544 | $61.14K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4